Recently, I came across an OIG announcement “Review of Medicare Part B Claims for Intravitreal Injections of Eylea and Lucentis” released in June 2019. Upon reading this announcement, I pulled […]
You are aware of the challenges facing hospitals these days: growing bad debt, payment constraints, ever-changing, unfunded regulatory requirements, staffing challenges, new mega tech competitors. The list goes on! So […]
Quality expert Cheryl Manchenton explores ways to reduce readmissions penalties.
Amy Truitt and Debbie Okonek, CDI leaders at Palmetto Health, discuss their organization’s shift toward quality focus.
I think it’s reasonable to say that most people working in health care are motivated to deliver high quality care to the people they serve. Because humans are complicated organisms, […]
Dr. Gordon Moore: Welcome to 3M’s Inside Angle Podcast. This is your host, Dr. Gordon Moore. With me today I have Dr. Geoffrey Rose, who is the chief of adult […]
As I look forward to pulling the turkey out of the oven tomorrow and placing it on the table between the gravy and the green bean casserole, I’m reminded of […]
In this webinar, Bobbie Starkey, RHIT, CCS-P, paints a broad picture of the components to consider if you are thinking of starting a CDI program in your Emergency Department.
The pressure to improve healthcare outcomes and reduce unnecessary use of healthcare resources weighs heavily on hospital and health system administrators working with tight margins. Success under value-based payment requires […]
I don’t know about you, but my head is spinning. On July 12, 2018, Administrator Verma released an email with some pretty stunning news. I’m going to focus on the […]
Roughly 40 percent of healthcare financial leaders say their organizations lack in-house expertise and staffing for extremely important activities, such as managing new regulations and payment models. The gaps put […]
In my last blog, I commented on being overcharged by my PBM for a medication that had been removed from their formulary – allegedly because the FDA pulled some old […]